Evaluating surrogate marker information using censored data
Author:
Affiliation:
1. RAND Corporation; 1776 Main Street Santa Monica 90401 CA U.S.A.
2. Department of Biostatistics; Harvard University; Boston 02115 MA U.S.A.
3. Department of Health, Research and Policy; Stanford University; Stanford 94305 CA U.S.A.
Funder
National Institutes of Health
Publisher
Wiley
Subject
Statistics and Probability,Epidemiology
Reference34 articles.
1. Are surrogate markers adequate to assess cardiovascular disease drugs;Temple;Journal of the American Medical Association,1999
2. Surrogate endpoints in clinical trials: definition and operational criteria;Prentice;Statistics in Medicine,1989
3. Statistical validation of intermediate endpoints for chronic diseases;Freedman;Statistics in Medicine,1992
4. A measure of the proportion of treatment effect explained by a surrogate marker;Wang;Biometrics,2002
5. Robust estimation of the proportion of treatment effect explained by surrogate marker information;Parast;Statistics in Medicine,2016
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proportion of treatment effect explained: An overview of interpretations;Statistical Methods in Medical Research;2024-07
2. Assessing heterogeneity in surrogacy using censored data;Statistics in Medicine;2024-05-29
3. Statistical Methods to Evaluate Surrogate Markers;Medical Care;2023-12-11
4. Flexible evaluation of surrogate markers with Bayesian model averaging;Statistics in Medicine;2023-12-11
5. Response heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors;Future Oncology;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3